Real-time reverse transcription-PCR quantification of vascular endothelial growth factor splice variants

Clinical Chemistry

Volumn 51, Issue 8, 2005, Pages 1518-1520

  Zygalaki, Eleni ^a   Stathopoulou, Aliki ^a   Kroupis, Christos ^b   Kaklamanis, Loukas ^b   Kyriakides, Zenon ^c   Kremastinos, Dimitrios ^b   Lianidou, Evi S ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c RED CROSS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ARTICLE; GENE; HUMAN; HUMAN CELL; PROTEIN VARIANT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VEGF GENE;

ALTERNATIVE SPLICING; CELL LINE, TUMOR; HUMANS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 23044452192     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.046987     Document Type: Article

References (14)

1. Ferrara N. VEGF and the quest for tumor angiogenesis factors. Nat Rev Cancer 2002;2:795-803.
2. Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to the human chromosome 6p21.3. Circulation 1996;93:1493-5.
3. Tisher E, Mitchell R, Hartmann T, Silva M, Gospodarowicz D, Fiddes J, et al. The human gene for vascular endothelial growth factor. J Biol Chem 1991;266:11947-54.
4. Ferrara N. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
5. 148 mRNA, a novel truncated splice variant. Clin Sci (Lond) 1999;97:303-12.
6. Lei J, Jiang A, Pei D. Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF 183. Biochim Biophys Acta 1998;14443:400-6.
7. Poltorak Z, Cohen T, Sivan R, Kandelis Y, Spira G, Vlodavsky I, et al. VEGF 145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 1997;272:7151-8.
8. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991;5: 1806-14.
9. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
10. Stimpfl M, Tong D, Fasching B, Schuster E, Obermair A, Leodolter S, et al. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Clin Cancer Res 2002;8:2253-9.
11. Wellmann S, Tillmann T, Paal K, Einsiedel H, Geilen W, Seifert G, et al. Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology. Clin Chem 2001;47:654-60.
12. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
13. Kroupis C, Stathopoulou A, Zygalaki E, Ferekidou L, Talieri M, Lianidou ES. Development and applications of a real-time quantitative RT-PCR method (QRT-PCR) for BRCA1 mRNA. Clin Biochem 2005;38:50-7.
14. Ovstebo R, Haug KB, Lande K, Kierulf P. PCR-based calibration curves for studies of quantitative gene expression in human monocytes: development and evaluation. Clin Chem 2003;49:425-32.